Nine ideas to improve the clinical management of HIV infected patients during the COVID-19 pandemic


antiretroviral therapy


Globally, in 2019, HIV infection was still responsible for 1.7 million new infections 2.2 and for 690,000 deaths in the same year. Tailored and new antiretroviral therapy (ART) regimens, individualised follow-up and new technologies to support data-sharing between health—care professional caring for people living with HIV (PLHIV) and to deliver ART to patients are desperately needed to reach the 90-90-90-90 ambitious goals. The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) virus, responsible for the Coronavirus-19 (COVID-19) pandemic that spread globally in 2020, posed a huge challenge for PLHIV and HIV physicians worldwide in terms of continuum of care.
In this paper we encourage “up-to-date patient-centred HIV medicine” and we give nine ideas to improve HIV management in clinical practice during the COVID-19 pandemic.


3. Velloza J, Delany-Moretlwe S, Baeten JM. Comprehensive HIV risk reduction interventions for 2020 and beyond: product choices and effective service-delivery platforms for individual needs and population-level impact. Curr Opin HIV AIDS. 2019 Sep;14(5):423-432. doi: 10.1097/COH.0000000000000567. PMID: 31261158.
4. Pinto RM, Park S. COVID-19 Pandemic Disrupts HIV Continuum of Care and Prevention: Implications for Research and Practice Concerning Community-Based Organizations and Frontline Providers. AIDS Behav. 2020;24(9):2486-2489. doi:10.1007/s10461-020-02893-3
5. Mantica G, Riccardi N, Terrone C, Gratarola A. Non-COVID-19 visits to emergency departments during the pandemic: the impact of fear. Public Health. 2020;183:40-41. doi:10.1016/j.puhe.2020.04.046
6. Giannini B, Riccardi N, Cenderello G, Di Biagio A, Dentone C, Giacomini M. From Liguria HIV Web to Liguria Infectious Diseases Network: How a Digital Platform Improved Doctors' Work and Patients' Care. AIDS Res Hum Retroviruses. 2018 Mar;34(3):239-240. doi: 10.1089/aid.2017.0064. Epub 2018 Feb 21. PMID: 29466022.
7. Ford N, Geng E, Ellman T, Orrell C, Ehrenkranz P, Sikazwe I, et al. (2020) Emerging priorities for HIV service delivery. PLoS Med 17(2): e1003028.
8. High KP, Brennan-Ing M, Clifford DB, et al. HIV and aging: state of knowledge and areas of critical need for research. A report to the NIH Office of AIDS Research by the HIV and Aging Working Group. J Acquir Immune Defic Syndr. 2012;60 Suppl 1(Suppl 1):S1-S18. doi:10.1097/QAI.0b013e31825a3668
10. d'Arminio Monforte A, Tavelli A, Cozzi-Lepri A, Castagna A, Passerini S, Francisci D, Saracino A, Maggiolo F, Lapadula G, Girardi E, Perno CF, Antinori A; Icona Foundation Study Group. Virological response and retention in care according to time of starting ART in Italy: data from the Icona Foundation Study cohort. J Antimicrob Chemother. 2020 Mar 1;75(3):681-689. doi: 10.1093/jac/dkz512. PMID: 31865395.
11. Jose S, Delpech V, Howarth A, Burns F, Hill T, Porter K, Sabin CA; UK CHIC Study Steering Committee. A continuum of HIV care describing mortality and loss to follow-up: a longitudinal cohort study. Lancet HIV. 2018 Jun;5(6):e301-e308. doi: 10.1016/S2352-3018(18)30048-1. PMID: 29893243; PMCID: PMC5990495.
12. Prinapori R, Giannini B, Riccardi N, Bovis F, Giacomini M, Setti M, Viscoli C, Artioli S, Di Biagio A. Predictors of retention in care in HIV-infected patients in a large hospital cohort in Italy. Epidemiol Infect. 2018 Apr;146(5):606-611. doi: 10.1017/S0950268817003107. Epub 2018 Feb 28. PMID: 29486818.
13. Saag MS, Gandhi RT, Hoy JF, et al. Antiretroviral Drugs for Treatment and Prevention of HIV Infection in Adults: 2020 Recommendations of the International Antiviral Society–USA Panel. JAMA. Published online October 14, 2020. doi:10.1001/jama.2020.17025
14. Ford N, Flexner C, Vella S, Ripin D, Vitoria M. Optimization and simplification of antiretroviral therapy for adults and children. Curr Opin HIV AIDS. 2013 Nov;8(6):591-9. doi: 10.1097/COH.0000000000000010. PMID: 24100871.
15. Nachega JB, Mugavero MJ, Zeier M, Vitória M, Gallant JE. Treatment simplification in HIV-infected adults as a strategy to prevent toxicity, improve adherence, quality of life and decrease healthcare costs. Patient Prefer Adherence. 2011;5:357-367. doi:10.2147/PPA.S22771
16. Di Carlo P, Immordino P, Mazzola G, et al. Determinants of HIV outpatient service utilization according to HIV parameters. J Int AIDS Soc. 2014;17(4 Suppl 3):19611. Published 2014 Nov 2. doi:10.7448/IAS.17.4.19611
17. Di Biagio A, Riccardi N, Signori A, et al. PrEP in Italy: The time may be ripe but who's paying the bill? A nationwide survey on physicians' attitudes towards using antiretrovirals to prevent HIV infection. PLoS One. 2017;12(7):e0181433. Published 2017 Jul 20. doi:10.1371/journal.pone.0181433
18. Santos, G., Ackerman, B., Rao, A. et al. Economic, Mental Health, HIV Prevention and HIV Treatment Impacts of COVID-19 and the COVID-19 Response on a Global Sample of Cisgender Gay Men and Other Men Who Have Sex with Men. AIDS Behav (2020).
19. Jacomet C, Linard F, Prouteau J, Lambert C, Ologeanu-Taddei R, Bastiani P, Dellamonica P. E-health. Patterns of use and perceived benefits and barriers among people living with HIV (PLHIV) and their physicians - Part 3: Telemedicine and collection of computerized personal information. Med Mal Infect. 2020
20. Bulstra, C.A., Hontelez, J.A., Ogbuoji, O., & Bärnighausen, T. (2019). Which delivery model innovations can support sustainable HIV treatment? African Journal of AIDS Research, 18, 315 - 323.
22. Dorward J, Drain PK, Garrett N. Point-of-care viral load testing and differentiated HIV care. Lancet HIV. 2018;5(1):e8-e9. doi:10.1016/S2352-3018(17)30211-4
24. Giannini B, Riccardi N, Cenderello G, Di Biagio A, Dentone C, Giacomini M. From Liguria HIV Web to Liguria Infectious Diseases Network: How a Digital Platform Improved Doctors' Work and Patients' Care. AIDS Res Hum Retroviruses. 2018 Mar;34(3):239-240. doi: 10.1089/aid.2017.0064. Epub 2018 Feb 21. PMID: 29466022.
25. Taramasso L, Dentone C, Alessandrini A, Bruzzone B, Icardi G, Garraffo R, De Macina I, Viscoli C, Di Biagio A; HIV/HCV Collaborative Liguria Group: Successful anti- retroviral therapy by using unusual antiretroviral combina- tions in heavily pre-treated patients: Two case reports. Int J STD AIDS 2015;26:831–834.
26. Cenderello G, Fanizza C, Marenco S, Nicolini LA, Artioli S, Baldissarro I, Dentone C, De Leo P, Di Biagio A. Cost per care of the first year of direct antiviral agents in the Liguria Region: a multicenter analysis. Clinicoecon Outcomes Res. 2017 May 22;9:281-293. doi: 10.2147/CEOR.S129859. PMID: 28579812; PMCID: PMC5446971.
27. Riccardi N, Giannini B, Borghesi ML, Taramasso L, Cattaneo E, Cenderello G, Toscanini F, Giacomini M, Pontali E, Cassola G, Viscoli C, Di Biagio A. Time to change the single-centre approach to management of patients with tuberculosis: a novel network platform with automatic data import and data sharing. ERJ Open Res. 2018 Feb
29. Martínez Sanz J, Vivancos MJ, Sánchez-Conde M, Gómez-Ayerbe C, Polo L, Labrador C, González P, Mesa A, Muriel A, Chamorro C, de la Fuente Y, Pérez Elías P, Uranga A, Herrero M, Ares S, Barea R, Moreno S, Pérez-Elías MJ. Hepatitis C and HIV combined screening in primary care: a cluster randomized trial. J Viral Hepat. 2020 Sep 26. doi: 10.1111/jvh.13413. Epub ahead of print. PMID: 32979880.
30. Petruccioli E, Chiacchio T, Navarra A, Vanini V, Cuzzi G, Cimaglia C, Codecasa LR, Pinnetti C, Riccardi N, Palmieri F, Antinori A, Goletti D. Effect of HIV-infection on QuantiFERON-plus accuracy in patients with active tuberculosis and latent infection. J Infect. 2020 May;80(5):536-546. doi: 10.1016/j.jinf.2020.02.009. Epub 2020 Feb 22. PMID: 32097688.
31. Madhav N, Oppenheim B, Gallivan M, et al. Pandemics: Risks, Impacts, and Mitigation. In: Jamison DT, Gelband H, Horton S, et al., editors. Disease Control Priorities: Improving Health and Reducing Poverty. 3rd edition. Washington (DC): The International Bank for Reconstruction and Development / The World Bank; 2017 Nov 27. Chapter 17.
32. Landon BE, Wilson IB, Wenger NS, et al. Specialty training and specialization among physicians who treat HIV/AIDS in the United States. J Gen Intern Med. 2002;17(1):12-22. doi:10.1046/j.1525-1497.2002.10401.x
33. Green M. A letter to a young HIV doctor. AIDS. 2020 Nov 1;34(13):1991-1992. doi: 10.1097/QAD.0000000000002670. PMID: 33009015.